CPIX

Cumberland Pharmaceuticals Inc

5.41

+0.29+5.66%

After Hours: 5.23 -0.18 -3.33%16:46 05/19 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE5.08/5.12

TODAY RANGE5.07-5.44

VOL113.22K

MARKET CAP81.06M

52 WEEK RANGE1.850-6.27

AVG VOL (3M)993.99K

% TURNOVER0.76%

TURNOVER--

P/E (TTM)-10.9051

% RANGE7.23%

EPS(TTM)-0.4961

P/E(FORWARD)37.43

P/B3.746

BVPS1.444

DIVIDEND--

P/S1.817

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP45.49M

SHARES OUTSTANDING14.98M

NEXT EARNINGS08/03-08/07

FREE FLOAT8.41M

LOT SIZE1

EX-DATE--

News

Press Releases

Financial Reports

Profile

PUBT·05/08 21:03
Cumberland Q1 FY26 swings to net loss of $3.29 million; net revenues fall 22.04% to $9.13 million
TipRanks·05/07 00:59
Cumberland Pharmaceuticals Pivots After Transformational Apotex Deal
NASDAQ·05/06 14:12
Cumberland Posts Loss in Q1 Amid $100M Apotex Deal Plan
Seeking Alpha·05/06 06:32
Cumberland outlines $100M Apotex deal while shifting to development-focused strategy
Reuters·05/05 22:26
Cumberland Pharmaceuticals Q1 revenue up 5%; to sell FDA‑approved brands to Apotex for $100 mln
Dow Jones·05/05 21:38
*Cumberland Pharma 1Q Rev $9.1M >CPIX
Seeking Alpha·05/05 21:27
Cumberland Pharmaceuticals Non-GAAP EPS of -$0.13, revenue of $9.1M
Reuters·05/05 21:00
CUMBERLAND PHARMACEUTICALS REPORTS Q1 2026 FINANCIAL RESULTS & COMPANY UPDATE
Dow Jones·05/05 21:00
*Cumberland Pharma 1Q Loss/Shr 22c >CPIX
Dow Jones·05/05 21:00
Press Release: CUMBERLAND PHARMACEUTICALS REPORTS Q1 2026 FINANCIAL RESULTS & COMPANY UPDATE
Dow Jones·05/05 21:00
Press Release: CUMBERLAND PHARMACEUTICALS REPORTS -2-
PUBT·04/29 10:46
RedHill Biopharma publishes corporate presentation on GI, infectious disease, oncology pipeline
PUBT·04/28 20:19
Cumberland Pharmaceuticals schedules Q1 results release and conference call
PR Newswire·04/28 20:05
CUMBERLAND PHARMACEUTICALS TO ANNOUNCE Q1 2026 FINANCIAL RESULTS & COMPANY UPDATE

Same Industry

Name/Symbol

Change%

Price

CPIX

MCK

Biogen Inc

BIIB

+0.83%

192.95

Amgen Inc

AMGN

-2.22%

326.31

SHPG

CELG-RT

Lilly Eli & Co

LLY

-1.67%

988.09

CELG

Therapeuticsmd Inc

TXMD

+0.50%

2.000

JNJ

Abbvie Inc

ABBV

-0.18%

210.39

Zoetis Inc

ZTS

-1.67%

74.22

GILD

NVO

BMY

ALXN

PFE

Sanofi FR

SNY

+0.01%

43.55

GCVRZ

Novartis

NVS

-1.13%

148.08

RDY

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.